Clinical trials for Breast cancer
184 currently recruiting clinical trials
Looking for clinical trials?
Clinical trial search is a complex process, with countless criteria to consider. Our AI assistant navigates this complexity with precise, expert-level analysis of the most relevant trials based on your medical profile. Our database is fully up to date, so you see only actively recruiting sites. It's fast and easy:
- Create your account
- Copy-paste your latest medical report
- Our AI-based assistant does the rest for you
Whether you are a patient or a doctor, create an account to find and apply for the most relevant clinical trials:
Phase 2
Breast cancer
Lung cancer
Prostate cancer
Colon cancer
Rectal cancer
Kidney cancer
Pancreas cancer
Liver and bile duct cancer
Bladder / Urinary Tract / Urethral cancer
Stomach and esophageal cancer
Endometrial cancer
Ovarian / Fallopian tubes / Peritoneum cancer
#NCT04116541
#2023-510567-35-00
Locally Advanced
Metastatic
Metastatic Castration-resistant
BRAF
1
2
3 or more
Systemic Treatment-Naive
Centre Léon Bérard (Lyon), IUCT Oncopôle (Toulouse), Institut Paoli-Calmettes (Marseille), ICANS - Institut de cancérologie Strasbourg Europe (Strasbourg), Centre François Baclesse (Caen ) (and 3 more...)
Centre Léon Bérard
Phase 2
Breast cancer
Lung cancer
Prostate cancer
Colon cancer
Rectal cancer
Kidney cancer
Pancreas cancer
Liver and bile duct cancer
Bladder / Urinary Tract / Urethral cancer
Stomach and esophageal cancer
Endometrial cancer
Ovarian / Fallopian tubes / Peritoneum cancer
#NCT04116541
#2023-510567-35-00
Locally Advanced
Metastatic
Metastatic Castration-resistant
ALK
1
2
3 or more
Systemic Treatment-Naive
Institut Paoli-Calmettes (Marseille), Gustave Roussy (Villejuif), Centre Léon Bérard (Lyon), Centre Antoine Lacassagne (Nice), Institut Bergonié (Bordeaux) (and 3 more...)
Centre Léon Bérard
Phase 2
Breast cancer
Lung cancer
Prostate cancer
Colon cancer
Rectal cancer
Kidney cancer
Pancreas cancer
Liver and bile duct cancer
Bladder / Urinary Tract / Urethral cancer
Stomach and esophageal cancer
Endometrial cancer
#NCT04116541
#2023-510567-35-00
Locally Advanced
Metastatic
Metastatic Castration-resistant
EGFR
MET
NTRK-1/2/3
RET
ROS-1
Other mutation
1
2
3 or more
Systemic Treatment-Naive
Gustave Roussy (Villejuif), Centre Léon Bérard (Lyon), Centre François Baclesse (Caen ), Centre Antoine Lacassagne (Nice), ICANS - Institut de cancérologie Strasbourg Europe (Strasbourg) (and 3 more...)
Centre Léon Bérard
Phase 2
Breast cancer
#NCT05800275
HER2 Positive
Metastatic
1
2
3 or more
Centre François Baclesse (Caen ), Institut Godinot (Reims), Centre Jean Perrin (Clermont Ferrand ), Centre Léon Bérard (Lyon), CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ) (and 5 more...)
UNICANCER
Phase 2
Breast cancer
#NCT06680596
#2024-515349-41-00
HER2 Low
HR Positive
Metastatic
None
Antibody Drug Conjugates (ADC)
Hormone therapy
Centre Antoine Lacassagne (Nice), Centre Eugene Marquis (Rennes), Centre Hospitalier Alpes-Léman CHAL (Contamine-sur-Arve), Centre Hospitalier d’Auxerre (Auxerre), Centre Hospitalier William Morey (Chalon-sur-Saône) (and 30 more...)
UNICANCER
Phase 2
Breast cancer
#NCT05386108
#2024-512878-98-00
HER2 Negative
HR Positive
Metastatic
1
2
3 or more
Chemotherapy
Targeted therapy
Hormone therapy
Systemic Treatment-Naive
Centre Hospitalier Universitaire de Poitiers - Site de la Milétrie (Poitiers), Centre Léon Bérard (Lyon), Centre de Cancérologie du Grand Montpellier (Montpellier), Hôpital Pitié Salpêtrière - AP-HP (Paris), Centre François Baclesse (Caen ) (and 4 more...)
Stemline Therapeutics, Inc.
Phase 2
Breast cancer
Prostate cancer
Colon cancer
Rectal cancer
Anal cancer
Kidney cancer
#NCT05732831
#2022-502645-99-00
Locally Advanced
Metastatic
Metastatic Castration-resistant
MTAP
1
2
3 or more
Systemic Treatment-Naive
Centre Léon Bérard (Lyon), Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest), Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain)
Tango Therapeutics
Phase 2
Breast cancer
#NCT05296746
#2023-508827-10-00
HER2 Negative
HR Positive
Localized
None
Systemic Treatment-Naive
Systemic Treatment-Naive
Centre Hospitalier de la Côte Basque (Bayonne), Centre Hospitalier Universitaire de Poitiers - Site de la Milétrie (Poitiers), IUCT Oncopôle (Toulouse), Centre Hospitalier Universitaire Dupuytren (Limoges), Hôpital Franco Britannique (Levallois-Perret) (and 20 more...)
Novartis
Phase 2
Breast cancer
#NCT05297617
#2024-514480-26-00
HER2 Negative
HR Positive
Localized
None
Surgery
Hormone therapy
Chemotherapy
CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ), Centre Hospitalier Universitaire Dupuytren (Limoges), Hôpital Privé Jean Mermoz - Ramsay Santé (Lyon), Centre Jean Perrin (Clermont Ferrand ), ICANS - Institut de cancérologie Strasbourg Europe (Strasbourg) (and 34 more...)
UNICANCER
Phase 2
Breast cancer
Lung cancer
Prostate cancer
Colon cancer
Rectal cancer
Anal cancer
Kidney cancer
Pancreas cancer
Liver and bile duct cancer
Stomach and esophageal cancer
#NCT05503797
#2024-513578-23-00
Neuroendocrine tumor
Locally Advanced
Metastatic
BRAF
1
2
3 or more
HRAS
KRAS G12C
KRAS non G12C
NRAS
Systemic Treatment-Naive
Hôpital Nord de Marseille (Marseille Cedex 20), Institut Bergonié (Bordeaux), Gustave Roussy (Villejuif), Hôpital Pitié Salpêtrière - AP-HP (Paris), IUCT Oncopôle (Toulouse) (and 2 more...)
Fore Biotherapeutics